TOBIN JAMES R
SEC Form 4 insider trading activity
TOBIN JAMES R has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including GMED, TMDX, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 16, 2026.
On the most recent filing, TOBIN JAMES R is listed as Director at GLOBUS MEDICAL INC. Inside the rolling window, TOBIN JAMES R reported no open-market purchases and 1 open-market sale totaling $2.2M in GMED.
Companies traded
Other insiders at GMED
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has TOBIN JAMES R made?
TOBIN JAMES R has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including GMED, TMDX since 2026.
Which companies does TOBIN JAMES R trade?
TOBIN JAMES R has filed SEC Form 4 disclosures for 2 companies, including GMED, TMDX.
When was TOBIN JAMES R's most recent SEC Form 4 filing?
TOBIN JAMES R's most recent SEC Form 4 filing on Tracefour is dated Sep 16, 2026.
What is TOBIN JAMES R's total buy and sell value in the current window?
Inside the rolling retention window, TOBIN JAMES R bought $0 and sold $2.2M based on SEC Form 4 filings.
What was TOBIN JAMES R's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,000 GMED shares on 2026-09-15, worth $2.2M, per SEC Form 4 filings.